E. Espinosa Arranz-rekin lankidetzan egindako argitalpenak (8)

1997

  1. Experience of oncopaz cooperative group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast

    Oncology (Switzerland), Vol. 54, Núm. 1, pp. 30-37

1996

  1. Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

    Cancer Chemotherapy and Pharmacology, Vol. 38, Núm. 2, pp. 191-194

  2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

    Cancer, Vol. 78, Núm. 2, pp. 211-216

1995

  1. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

    European Journal of Cancer, Vol. 31, Núm. 13-14, pp. 2215-2219

  2. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ cooperative group

    Cancer Chemotherapy and Pharmacology, Vol. 36, Núm. 3, pp. 255-258

1994

  1. Comparison of two chemotherapeutic regimens - mitomycin + vindesine 4-cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) - in advanced non-small-cell lung cancer

    Annals of Oncology, Vol. 5, Núm. 4, pp. 323-327

  2. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer

    European Journal of Cancer, Vol. 30, Núm. 11, pp. 1733-1734

1991

  1. Descriptive study of the care of oncologic patients at the emergency service of a general hospital

    Revista clínica española, Vol. 188, Núm. 7, pp. 345-348